All the news Showing 10 of 330 articles from: Access to medicines & diagnosticsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Vaccine “Unaffordable” in Hepatitis B Endemic Liberia Front Page Africa / 09 March 2022 Hepatitis C and Tuberculosis Long-Acting Medicines: Analysis of Patenting Trends and Implications for Access Treatment Action Group / 04 November 2021 Russia struggling with adequate access to hepatitis C drugs Pharma Letter / 25 October 2021 Public health partnership launched to tackle silent epidemic of hepatitis C MSF / 09 August 2021 New Report Shows Discriminatory Sobriety Restrictions Undermine Public Health Efforts to Eliminate Hepatitis C National Viral Hepatitis Roundtable / 21 May 2021 Accelerating access to hepatitis C diagnostics and treatment World Health Organization / 19 February 2021 Public-sector hepatitis C treatment programmes expanding in lower- and middle-income countries Keith Alcorn / 08 January 2021 Public-sector hepatitis C treatment programmes have cured tens of thousands of people in lower- and lower-middle-income countries with the aid of low-cost direct-acting antivirals and diagnostics, a simplified approach to treatment and large-scale ... 2.5 million people in Africa need urgent hepatitis B treatment Keith Alcorn / 09 December 2020 Around 2.5 million people with hepatitis B in sub-Saharan Africa already have cirrhosis and need immediate antiviral treatment, a systematic review of published studies reports this month in the journal Liver International. Approximately ... State Policies Create Barriers to Hepatitis C Elimination Hep Mag / 17 November 2020 Many People on Medicaid and Prisoners Still Lack Access to Hepatitis C Treatment Hep Mag / 28 September 2020 ← First12345...33Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Email bulletin archive